Mettler-Toledo International, Inc. (NYSE:MTD) Receives Consensus Recommendation of “Hold” from Brokerages

Mettler-Toledo International, Inc. (NYSE:MTD) has earned an average recommendation of “Hold” from the thirteen brokerages that are covering the firm, MarketBeat.com reports. Seven analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $1,441.6667.

Several research firms recently issued reports on MTD. Morgan Stanley assumed coverage on shares of Mettler-Toledo International in a report on Tuesday, December 2nd. They set an “equal weight” rating and a $1,550.00 price objective for the company. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Mettler-Toledo International in a research report on Monday, December 29th. Stifel Nicolaus boosted their price objective on Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. Citigroup increased their target price on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Finally, Bank of America raised Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target on the stock in a research report on Monday, December 15th.

Insider Activity

In other Mettler-Toledo International news, insider La Guerroniere Marc De sold 6,880 shares of the stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $1,450.00, for a total value of $9,976,000.00. Following the completion of the sale, the insider directly owned 187 shares of the company’s stock, valued at $271,150. This represents a 97.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Shawn Vadala sold 1,895 shares of the firm’s stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $1,455.52, for a total transaction of $2,758,210.40. Following the completion of the sale, the chief financial officer owned 5,288 shares in the company, valued at $7,696,789.76. This represents a 26.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 19,565 shares of company stock worth $28,683,737. Corporate insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

A number of hedge funds have recently modified their holdings of the company. Corient Private Wealth LLC raised its holdings in shares of Mettler-Toledo International by 91.8% in the second quarter. Corient Private Wealth LLC now owns 140,267 shares of the medical instruments supplier’s stock valued at $164,775,000 after buying an additional 67,149 shares during the last quarter. Stance Capital LLC acquired a new stake in Mettler-Toledo International in the 2nd quarter valued at about $2,012,000. Claret Asset Management Corp bought a new position in shares of Mettler-Toledo International in the second quarter worth about $235,000. Sound Income Strategies LLC lifted its position in shares of Mettler-Toledo International by 477.8% during the second quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock worth $61,000 after purchasing an additional 43 shares in the last quarter. Finally, Campbell & CO Investment Adviser LLC bought a new stake in shares of Mettler-Toledo International during the third quarter valued at approximately $2,210,000. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Price Performance

Mettler-Toledo International stock opened at $1,391.96 on Friday. Mettler-Toledo International has a one year low of $946.69 and a one year high of $1,525.17. The company’s fifty day moving average price is $1,433.97 and its two-hundred day moving average price is $1,350.67. The company has a market capitalization of $28.44 billion, a price-to-earnings ratio of 34.71, a PEG ratio of 4.17 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.The company had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $997.36 million. During the same quarter in the prior year, the company posted $10.21 EPS. The firm’s revenue was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. As a group, sell-side analysts anticipate that Mettler-Toledo International will post 42.71 earnings per share for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.